# Hepatic Arterial Infusion (HAI) of Abraxane

> **NCT00732836** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 64 (actual)

## Conditions studied

- Liver Cancer
- Advanced Cancers
- Solid Tumors

## Interventions

- **DRUG:** HAI Abraxane
- **PROCEDURE:** Hepatic Artery Catheter
- **DRUG:** IV Abraxane

## Key facts

- **NCT ID:** NCT00732836
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2016-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00732836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00732836, "Hepatic Arterial Infusion (HAI) of Abraxane". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00732836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*